A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
about
Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasisMolecular mechanisms for enhanced DNA vaccine immunogenicity.A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer's disease model.DNA Aβ42 vaccination as possible alternative immunotherapy for Alzheimer disease.Alzheimer's disease: is a vaccine possible?A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-betaCo-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP miceDNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c miceProtection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c miceImmunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease.Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.DNA vaccines for prostate cancer.
P2860
Q27024824-AE316BD8-E066-4108-85A5-BF0DB23DDD64Q30366743-C48EED70-F669-4EEE-BAE9-880CF0C3B6B1Q30581976-8EE37C7F-EEE0-4BF4-9C89-F49A1DC7C026Q33829380-FF987D2C-BA90-470A-85DC-03AE5903A0F0Q33861011-27276057-2BBC-4029-996C-4E52C8101F45Q34094661-EADE1FFE-0DE7-485F-AD21-42273E4F92CFQ34948575-56C60B49-A799-4976-89C0-8CEB111A019FQ35023899-86803BE3-3866-4659-9B0F-3725A540E374Q36246596-74E3210E-EA60-4AAC-931E-D488FD3D7F71Q36484413-B36FB239-214F-4E98-AD13-14DD053D3F44Q38112430-C46E8768-A46C-4F08-BA89-FE70DF7B1F1BQ38187861-A72E6D21-3B18-4FF0-8B8A-81869D86B754Q38540633-11A104F1-DFD9-46E7-8612-663F47A279FAQ39373266-8119E982-022E-4A0E-A2E4-58BA4700F9AAQ50532074-3D0C531A-528E-4A5B-AC21-C1A679815A81Q51142505-E52E4B88-DC66-4222-AD20-AF1873CBC29C
P2860
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease.
@ast
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease.
@en
type
label
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease.
@ast
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease.
@en
prefLabel
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease.
@ast
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease.
@en
P2093
P2860
P50
P1476
A peptide prime-DNA boost immu ...... vaccine for Alzheimer disease
@en
P2093
Olaf Stüve
Roger N Rosenberg
P2860
P356
10.1016/J.JNEUROIM.2012.09.008
P577
2012-10-01T00:00:00Z